NLS Pharmaceutics AG Cash Flow Quality Index

Latest as of March 2025: -49.75x

NLS Pharmaceutics AG cash flow quality index. NLS Pharmaceutics AG (NLSP) has a Cash Flow Quality Index of -49.75x as of March 2025. Operating cash flow of $-2.74 Million is below net income of $55.02K, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of NLS Pharmaceutics AG to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-49.75x

Operating CF / Net Income

Operating Cash Flow

$-2.74 Million

USD

Net Income

$55.02K

USD

Data as of

Mar 2025

Most recent filing

NLS Pharmaceutics AG Cash Flow Quality Index by Year (None–None)

NLS Pharmaceutics AG cash flow quality index by year from None to None. Year-by-year earnings quality comparison for NLS Pharmaceutics AG. For the full cash flow conversion analysis, see NLS Pharmaceutics AG (NLSP) cash conversion ratio.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.